Viewing Study NCT02973269


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2026-02-23 @ 12:20 PM
Study NCT ID: NCT02973269
Status: TERMINATED
Last Update Posted: 2024-04-03
First Post: 2016-11-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis
Sponsor: Revance Therapeutics, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: RT002-CL008
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View